Drug intelligence / Profile preview

adenosine + cobalamin

Development stage
Unknown
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral, Intravenous, Intramuscular, Subcutaneous, Sublingual
01

Overview

Adenosine + cobalamin is a combination of two distinct bioactive molecules. Adenosine is a purine nucleoside involved in energy transfer (as ATP and ADP) and signal transduction via activation of specific adenosine receptors. It is used clinically as an antiarrhythmic agent for the acute treatment of paroxysmal supraventricular tachycardia due to its ability to slow conduction through the atrioventricular node by agonizing A1, A2a, A2b, and A3 adenosine receptors[7]. Cobalamin refers to vitamin B12 compounds; its active forms include methylcobalamin (cytosolic) and adenosylcobalamin (mitochondrial), both essential for DNA synthesis, red blood cell formation, myelin synthesis in the nervous system, fatty acid metabolism, and amino acid metabolism[1][3][5]. Combination products containing both active forms of B12 are marketed as dietary supplements for optimal coverage of cellular metabolic needs[4][6][8]. There is no evidence that "adenosine + cobalamin" exists as a single pharmaceutical product or has unique clinical indications beyond those established for each component.

Other names
adenosine and cobalaminadenosylcobalamin and adenosineadenosine plus vitamin B12
02

Targets

ADORA1 (Adenosine receptor A1 subtype)ADORA2A (Adenosine A₂A Receptor)ADORA2B (Adenosine A2B receptor)ADORA3 (Adenosine A3 receptor)MTR (Methionine synthase)MMUT (Methylmalonyl-coenzyme A mutase)

Beyond the preview

Go deeper on adenosine + cobalamin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on adenosine + cobalamin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call